Home > Research > Researchers > Professor David Allsop > Publications

Professor David Allsop

Formerly at Lancaster University

  1. 2018
  2. Published

    Liposome delivery systems for the treatment of Alzheimer’s disease

    Ross, C., Taylor, M. N., Fullwood, N. J. & Allsop, D., 12/12/2018, In: International Journal of Nanomedicine. 2018, 13, p. 8507-8522 16 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  3. Published

    Raman spectroscopy to diagnose Alzheimer's disease and dementia with Lewy bodies in blood

    Paraskevaidi, M., Morais, C., Halliwell, D., Mann, D., Allsop, D., Martin-Hirsch, P. & Martin, F. L., 2018, In: ACS Chemical Neuroscience. 9, 11, p. 2786–2794 9 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  4. Published

    Untangled - peptide-based inhibitors of tau aggregation as a potential treatment for Alzheimer's disease

    Allsop, D., Aggidis, A., Fullwood, N. J., Taylor, M. N., Foulds, P., Vincent, S. & Dale, M., 2018, In: Journal of Prevention of Alzheimer's Disease. 5, Suppl 1, p. S15-S16 2 p.

    Research output: Contribution to Journal/MagazineMeeting abstract

  5. 2017
  6. Published

    Development of proteolytically stable N-methylated peptide inhibitors of aggregation of the amylin peptide implicated in type 2 diabetes

    Obasse, I. C., Taylor, M. N., Fullwood, N. J. & Allsop, D., 6/12/2017, In: Interface Focus. 7, 6, 11 p., 20160127.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  7. Published

    Increased levels of plasma total tau in adult Down syndrome

    Kasai, T., Tatebe, H., Kondo, M., Ishii, R., Ohmichi, T., Yeung, W. T. E., Morimoto, M., Chiyonobu, T., Terada, N., Allsop, D., Nakagawa, M., Mizuno, T. & Tokuda, T., 30/11/2017, In: PLoS ONE. 12, 11, 12 p., e0188802.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  8. Published

    A novel approach to the therapy of Alzheimer's disease based on peptide nanoliposome inhibitors of Aβ and tau aggregation

    Allsop, D., Taylor, M. N., Fullwood, N. J., Michael, M., Aggidis, A., Vincent, S. & Dale, M., 1/11/2017, In: Journal of Prevention of Alzheimer's Disease. 4, 4, p. 385-386 2 p.

    Research output: Contribution to Journal/MagazineMeeting abstractpeer-review

  9. Published

    α-Synuclein interacts with lipoproteins in plasma

    Nouri Emamzadeh, F. & Allsop, D., 10/2017, In: Journal of Molecular Neuroscience . 63, 2, p. 165-172 8 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  10. Published

    Differential diagnosis of Alzheimer’s disease using spectrochemical analysis of blood

    Paraskevaidi, M., Morais, C., Lima, K., Snowden, J., Saxon, J., Richardson, A., Jones, M., Mann, D., Allsop, D., Martin-Hirsch, P. & Martin, F., 19/09/2017, In: Proceedings of the National Academy of Sciences of the United States of America. 114, 38, p. E7929–E7938 10 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  11. Published

    Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and Down syndrome

    Tatebe, H., Kasai, T., Ohmichi, T., Kishi, Y., Kakeya, T., Waragai, M., Kondo, M., Allsop, D. & Tokuda, T., 4/09/2017, In: Molecular Neurodegeneration. 12, 63, 11 p., 63.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  12. Published

    Aβ levels in the jugular vein and high molecular weight Aβ oligomer levels in CSF can be used as biomarkers to indicate the anti-amyloid effect of IVIg for Alzheimer's disease

    Kasai, T., Kondo, M., Ishii, R., Tanaka, A., Ataka, S., Shimada, H., Tomiyama, T., Mori, H., Taylor, M. N., Allsop, D., Nakagawa, M., Mizuno, T. & Tokuda, T., 10/04/2017, In: PLoS ONE. 12, 4

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

Previous 1 2 3 4 5 6 7 8 ...16 Next

Back to top